Versant Venture Management, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001560009
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2025 · 8 positions · Total reported value $82.14M · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 12.5% · 0 new · 1 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -44.9% · vs SPY -47.0% · Prev Value $162.61M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -13.5% · vs SPY -15.6% · Latest Value $109.10M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2025 13F filing, Versant Venture Management, LLC disclosed 8 equity positions with a combined reported value of $82.14M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt.
The largest disclosed positions as of Q2 2025 were GLUE ($25.49M), CRSP ($24.25M), JBIO ($15.24M). By sector, the heaviest allocations are Health Care 94.2%, Other 5.8%. Versus the prior quarter, allocation shifted toward Health Care (+2.2pp) and away from Other (-2.2pp).
Versus the prior quarter, Versant Venture Management, LLC opened 0 new positions, trimmed 1 and fully exited 0, a turnover rate of 12.5% of positions. The portfolio's overlap with the prior quarter was 88% of names.
The largest new positions opened in Q2 2025 were JBIO ($15.24M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2025)
- JBIO JADE BIOSCIENCES INC · $15.24M
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Versant Venture Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Versant Venture Management, LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 8 US equity positions with a combined value of $162.61M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 8 positions · $162.61M reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: GLUE (MONTE ROSA THERAPEUTICS INC) at 47.3%
- Average position size: $20.33M
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 1 reduced
- 7 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
5.65M | $25.49M | 31.04% | Hold | |
| 2 |
|
498.56K | $24.25M | 29.52% | Hold | |
| 3 |
|
1.53M | $15.24M | 18.56% | New | |
| 4 |
|
2.01M | $8.39M | 10.22% | Hold | |
| 5 |
|
2.65M | $3.68M | 4.48% | Hold | |
| 6 |
|
542.63K | $2.15M | 2.62% | Reduce | |
| 7 |
|
269.77K | $1.83M | 2.23% | Reduce | |
| 8 |
|
506.82K | $1.09M | 1.33% | Hold |
FAQ
What did Versant Venture Management, LLC buy in 2025-Q2?
In its 2025-Q2 13F filing, Versant Venture Management, LLC reported 8 equity positions worth $82.14M in aggregate; its largest disclosed positions were GLUE ($25.49M), CRSP ($24.25M), JBIO ($15.24M).
How large is Versant Venture Management, LLC's portfolio?
Versant Venture Management, LLC reported $82.14M of long equity holdings across 8 positions as of 2025-Q2. Top-10 holdings account for 100.0% of reported value.
What is Versant Venture Management, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.